GeneDx Holdings (WGS) Retained Earnings (2020 - 2026)

GeneDx Holdings (WGS) has reported Retained Earnings for 7 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Retained Earnings rose 4.55% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 4.55% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 5.25% from the prior year.
• Retained Earnings was $1.7 billion for Q2 2026 at GeneDx Holdings, roughly flat from $1.7 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $1.7 billion in Q2 2026 and troughed at $981.8 million in Q1 2022.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings surged 342.14% in 2022 and increased 0.89% in 2024, its largest moves.
• Over 5 years, Retained Earnings stood at $1.4 billion in 2022, then increased by 10.86% to $1.5 billion in 2023, then rose by 4.52% to $1.6 billion in 2024, then rose by 5.25% to $1.7 billion in 2025, then grew by 1.05% to $1.7 billion in 2026.
• The last three Retained Earnings figures came in at $1.7 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.7 billion (Q4 2025), per Business Quant data.